A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background: Research suggests that only fifty percent of patients with major depression respond to psychotherapy or pharmacological treatment, and relapse is common. Therefore, there is interest in elucidating factors that help predict clinical response. Cognitive impairment is a key feature of depression, which often persists beyond remission; thus, the aim of this systematic review was to determine whether baseline cognitive functioning can predict treatment outcomes in individuals with depression. Method: Studies examining cognitive predictors of treatment response in depression were identified using Pub Med and Web of Science databases. Given the heterogeneity of outcome measures, the variety of treatment protocols, and the differing ways in which data was presented and analysed, a narrative rather than meta-analytic review technique was used. Results: Thirty-nine studies met inclusion criteria. Findings in younger adult samples were inconclusive. There was some evidence for a predictive effect of executive function and to a lesser extent, psychomotor speed, on treatment response. There was no evidence of learning or memory being associated with treatment response. In older-aged samples, the evidence was much more consistent, suggesting that poor executive function predicts poor response to SSRIs. Conclusions: Findings from the present review suggest that certain aspects of cognitive functioning, particularly executive function, may be useful in predicting treatment response in depression. This is certainly the case in elderly samples, with evidence suggesting that poor executive functioning predicts poor response to SSRIs. With further research, baseline cognitive functioning may serve as a factor which helps guide clinical decision making. Moreover, cognitive deficits may become targets for specific pharmacological or psychological treatments, with the hope of improving overall outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Cognition and Depression: Current Status and Future Directions
Gotlib, I. H., & Joormann, J. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131305 · Cited by 2,420
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Depression: Perspectives from Affective Neuroscience
Davidson, R. J., Pizzagalli, D., Nitschke, J. B., & Putnam, K. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135148 · Cited by 1,138
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842 · cited 2×
“Clinical factors predict differential response to treatments to a limited extent, leaving clinicians to choose first-line treatment on the basis of likely side effects, availability and their own clinical experience (4).”
BackgroundMethodSelf-citationNeurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Cognitive impairment in euthymic major depressive disorder: a meta-analysis
Bora, E., Harrison, B. J., Yücel, M., & Pantelis, C. (2013) · Psychological Medicine · doi:10.1017/s0033291712002085 · Cited by 551
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535
Khan, A., Leventhal, R. M., Khan, S. R., & Brown, W. A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00007 · Cited by 456
Siegle, G. J., Ghinassi, F., & Thase, M. E. (2007) · Cognitive Therapy and Research · doi:10.1007/s10608-006-9118-6 · Cited by 444
Thase, M. E., Friedman, E. S., Biggs, M. M., Wisniewski, S. R., Trivedi, M. H., Luther, J. F., Fava, M., Nierenberg, A. A., McGrath, P. J., Warden, D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.739 · Cited by 332
Executive dysfunction and the course of geriatric depression
Alexopoulos, G. S., Kiosses, D. N., Heo, M., Murphy, C. F., Shanmugham, B., & Gunning-Dixon, F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.024 · Cited by 317 · cited 2×
“Five of the studies found that deficits in executive functioning were associated with poor remission rates/antidepressant response (combined n= 341) (26, 28, 29, 32, 34, 35).”
BackgroundMahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y., & Keefe, R. S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.52 · Cited by 307
Prefrontal Dysfunction and Treatment Response in Geriatric Depression
Kalayam, B., & Alexopoulos, G. S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.8.713 · Cited by 263 · cited 2×
“One 6week study (n = 49) and one 12-month study (n = 177) found an association between poorer psychomotor speed and poor treatment response (46, 48), whilst two studies (n = 252) did not (47).”
BackgroundHarmer, C. J., Hill, S. A., Taylor, M. J., Cowen, P. J., & Goodwin, G. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.990 · Cited by 262
Shilyansky, C., Williams, L. M., Gyurak, A., Harris, A., Usherwood, T., & Etkin, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00012-2 · Cited by 249
Executive dysfunction predicts nonresponse to fluoxetine in major depression
Dunkin, J. J., Leuchter, A. F., Cook, I. A., Kasl-Godley, J. E., Abrams, M., & Rosenberg-Thompson, S. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00157-3 · Cited by 221
Longitudinal Assessment of Neuropsychological Function in Major Depression
Douglas, K. M., & Porter, R. J. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903279887 · Cited by 217 · cited 1×
“Although aspects of these cognitive deficits may resolve following successful treatment for some individuals, it is often the case that they persist beyond remission (7, 8).”
BackgroundInfluentialSelf-citationAlexopoulos, G. S., Raue, P. J., Kiosses, D. N., Mackin, R. S., Kanellopoulos, D., McCulloch, C., & Areán, P. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.177 · Cited by 199
MAJER, M., ISING, M., KÜNZEL, H., BINDER, E. B., HOLSBOER, F., MODELL, S., & ZIHL, J. (2004) · Psychological Medicine · doi:10.1017/s0033291704002697 · Cited by 180 · cited 1×
“In five of the samples (total n = 291), poorer executive function/attention was associated with poorer response to various pharmacological treatments (37, 39, 40, 42, 43).”
BackgroundPrevalence of cognitive impairment in major depression and bipolar disorder
Douglas, K. M., Gallagher, P., Robinson, L. J., Carter, J. D., McIntosh, V. V., Frampton, C. M., Watson, S., Young, A. H., Ferrier, I. N., & Porter, R. J. (2018) · Bipolar Disorders · doi:10.1111/bdi.12602 · Cited by 167
Self-citationSaveanu, R., Etkin, A., Duchemin, A.-M., Goldstein-Piekarski, A., Gyurak, A., Debattista, C., Schatzberg, A. F., Sood, S., Day, C. V. A., Palmer, D. M., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.12.018 · Cited by 151 · cited 2×
“In the iSPOT study, and in meta-analyses, there was no difference in overall efficacy between these three antidepressants (56, 60).”
BackgroundMethodResponse Inhibition Predicts Poor Antidepressant Treatment Response in Very Old Depressed Patients
Sneed, J. R., Roose, S. P., Keilp, J. G., Krishnan, K. R. R., Alexopoulos, G. S., & Sackeim, H. A. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180302513 · Cited by 146
Watson, S., Gallagher, P., Porter, R. J., Smith, M. S., Herron, L. J., Bulmer, S., Young, A. H., & Ferrier, I. N. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.029 · Cited by 145 · cited 1×
“For example, the antidepressant Vortioxetine has been shown to improve psychomotor and verbal memory function in moderate to severe depression (9), while RU486 has been shown to improve spatial working memory in the depressed phase of bipolar disorder (10).”
BackgroundSelf-citationMurrough, J. W., Burdick, K. E., Levitch, C. F., Perez, A. M., Brallier, J. W., Chang, L. C., Foulkes, A., Charney, D. S., Mathew, S. J., & Iosifescu, D. V. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.298 · Cited by 142
Prefrontal Neuropsychological Predictors of Treatment Remission in Late-Life Depression
Potter, G. G., Kittinger, J. D., Ryan Wagner, H., Steffens, D. C., & Ranga Rama Krishnan, K. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300551 · Cited by 132 · cited 6×
“One 6week study (n = 49) and one 12-month study (n = 177) found an association between poorer psychomotor speed and poor treatment response (46, 48), whilst two studies (n = 252) did not (47).”
BackgroundInfluentialShiroma, P. R., Albott, C. S., Johns, B., Thuras, P., Wels, J., & Lim, K. O. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714001011 · Cited by 126
Executive Dysfunction, Heart Disease Burden, and Remission of Geriatric Depression
Alexopoulos, G. S., Kiosses, D. N., Murphy, C., & Heo, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300557 · Cited by 117 · cited 2×
“Five of the studies found that deficits in executive functioning were associated with poor remission rates/antidepressant response (combined n= 341) (26, 28, 29, 32, 34, 35).”
BackgroundNeurocognitive Correlates of Response to Treatment in Late-Life Depression
Story, T. J., Potter, G. G., Attix, D. K., Welsh-Bohmer, K. A., & Steffens, D. C. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31817e739a · Cited by 117 · cited 4×
“(48) (n = 177) examined response to a standardized treatment algorithm over one year and found no association with executive function performance (48).”
BackgroundInfluentialPimontel, M. A., Rindskopf, D., Rutherford, B. R., Brown, P. J., Roose, S. P., & Sneed, J. R. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.05.010 · Cited by 110
Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients
Taylor, B. P., Bruder, G. E., Stewart, J. W., McGrath, P. J., Halperin, J., Ehrlichman, H., & Quitkin, F. M. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.73 · Cited by 109 · cited 14×
“Four shorter treatment trials (five samples), examined predictors of response to selective serotonin reuptake inhibitors (SSRIs).”
BackgroundInfluentialMurrough, J. W., Collins, K. A., Fields, J., DeWilde, K. E., Phillips, M. L., Mathew, S. J., Wong, E., Tang, C. Y., Charney, D. S., & Iosifescu, D. V. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.10 · Cited by 109 · cited 1×
“Dopaminergic transmission within prefrontal-subcortical circuits has been implicated in several cognitive processes, including psychomotor function (64); further, Ketamine has been shown to modulate dopamine transmission within these brain regions (65, 66).”
BackgroundPorter, R. J., Bowie, C. R., Jordan, J., & Malhi, G. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413502090 · Cited by 85
Self-citationNeuropsychological characteristics as predictors of SSRI treatment response in depressed subjects
Gorlyn, M., Keilp, J. G., Grunebaum, M. F., Taylor, B. P., Oquendo, M. A., Bruder, G. E., Stewart, J. W., Zalsman, G., & Mann, J. J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0084-x · Cited by 84 · cited 13×
“Four shorter treatment trials (five samples), examined predictors of response to selective serotonin reuptake inhibitors (SSRIs).”
BackgroundMethodInfluentialDoes Cognition Predict Treatment Response and Remission in Psychotherapy for Late-Life Depression?
Beaudreau, S. A., Rideaux, T., O'Hara, R., & Arean, P. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.09.003 · Cited by 43 · cited 2×
“Two studies have examined the association between cognitive function and response to psychotherapy in older-aged samples with depression (53, 54).”
BackgroundAlexopoulos, G. S., Manning, K., Kanellopoulos, D., McGovern, A., Seirup, J. K., Banerjee, S., & Gunning, F. (2015) · Psychological Medicine · doi:10.1017/s0033291715001075 · Cited by 43 · cited 2×
“Five of the studies found that deficits in executive functioning were associated with poor remission rates/antidepressant response (combined n= 341) (26, 28, 29, 32, 34, 35).”
BackgroundMorimoto, S. S., Gunning, F. M., Wexler, B. E., Hu, W., Ilieva, I., Liu, J., Nitis, J., & Alexopoulos, G. S. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.06.010 · Cited by 35 · cited 3×
“Two studies have examined the association between cognitive function and response to psychotherapy in older-aged samples with depression (53, 54).”
Background
Cited by
Effects of MDMA-assisted therapy for PTSD on self-experience
van der Kolk, B. A., Wang, J. B., Yehuda, R., Bedrosian, L., Coker, A. R., Harrison, C., Mithoefer, M., Yazar-Klosinki, B., Emerson, A., & Doblin, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295926 · Cited by 55
Dealing with heterogeneity of cognitive dysfunction in acute depression: A clustering approach
Vicent-Gil, M., Portella, M. J., Serra-Blasco, M., Navarra-Ventura, G., Crivillés, S., Aguilar, E., Palao, D., & Cardoner, N. (2021) · Psychological Medicine · doi:10.1017/s0033291720001567 · Cited by 28
Dam, V. H., Stenbæk, D. S., Köhler-Forsberg, K., Ip, C., Ozenne, B., Sahakian, B. J., Knudsen, G. M., Jørgensen, M. B., & Frokjaer, V. G. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02240-1 · Cited by 27
“In recent years, cognitive functions have been highlighted as a promising candidate for monitoring and even predicting treatment response to antidepressant drugs [5, 6].”
BackgroundAng, Y.-S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291720004286 · Cited by 12
Pan, W.-G., Hu, X.-Y., Zhu, D.-D., Li, L., Bao, F., Ren, L., Mao, P.-X., Ma, X., Ren, Y.-P., & Tang, Y.-L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1240261 · Cited by 12
Metadata
- Authors
- Groves, S. J., Douglas, K. M., & Porter, R. J.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2018-08-28
- Volume
- 9
- Pages
- 382-382
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2889140718
- Cited by
- 105
- References
- 38
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.